Immunogenicity, effectiveness, and safety of measles vaccination in infants younger than 9 months: a systematic review and meta-analysis

BACKGROUND: Measles is an important cause of death in children, despite the availability of safe and cost-saving measles-containing vaccines (MCVs). The first MCV dose (MCV1) is recommended at 9 months of age in countries with ongoing measles transmission, and at 12 months in countries with low risk...

Full description

Saved in:
Bibliographic Details
Published in:Lancet Infect Dis
Main Authors: Nic Lochlainn, Laura M, de Gier, Brechje, van der Maas, Nicoline, Strebel, Peter M, Goodman, Tracey, van Binnendijk, Rob S, de Melker, Hester E, Hahné, Susan J M
Format: Artigo
Language:Inglês
Published: Elsevier Science ;, The Lancet Pub. Group 2019
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6838664/
https://ncbi.nlm.nih.gov/pubmed/31548079
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1473-3099(19)30395-0
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items